Health Care & Life Sciences » Pharmaceuticals | Livzon Pharmaceutical Group Inc.

Livzon Pharmaceutical Group Inc. | Mutual Funds

Mutual Funds that own Livzon Pharmaceutical Group Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
UBS (Lux) Equity Fund - China Opportunity
11,384,380
4.63%
0
1.22%
01/31/2018
Government Pension Fund - Global (The)
7,240,771
2.94%
-492,581
0%
12/31/2017
Vanguard Total International Stock Index Fund
1,745,437
0.71%
0
0%
07/31/2018
1,170,000
0.48%
122,200
2.22%
12/31/2017
Vanguard Emerging Markets Stock Index Fund
1,131,130
0.46%
-35,000
0.01%
07/31/2018
1,000,857
0.41%
-273,910
3.49%
12/31/2017
Aviva Investors - Emerging Markets Equity Small Cap Fund
1,000,118
0.41%
-1
1.09%
06/30/2018
DFA Emerging Markets Small Cap Series
919,664
0.37%
0
0.05%
01/31/2018
Value Partners Intelligent Funds - China Convergence Fund
905,866
0.37%
-609,050
1.12%
12/31/2017
810,524
0.33%
-177,450
2.36%
12/31/2016

About Livzon Pharmaceutical Group

View Profile
Address
Headquarter Building
Zhuhai Guangdong 519090
China
Employees -
Website http://www.livzon.com.cn
Updated 07/08/2019
Livzon Pharmaceutical Group, Inc. engages in the research and development, production, and distribution of pharmaceutical products. It offers drug preparation products, bulk medicines and intermediates, and diagnostic reagents and equipment. The company was founded on March 1, 1992 and is headquartered in Zhuhai, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.